You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
|
|---|---|
| Published in |
Arthritis & Rheumatism, October 2009
|
| DOI | 10.1002/art.24941 |
| Pubmed ID | |
| Authors |
Johan Askling, Ronald F. van Vollenhoven, Fredrik Granath, Pauline Raaschou, C. Michael Fored, Eva Baecklund, Christina Dackhammar, Nils Feltelius, Lars Cöster, Pierre Geborek, Lennart T. Jacobsson, Staffan Lindblad, Solbritt Rantapää‐Dahlqvist, Tore Saxne, Lars Klareskog |
| Abstract |
To determine the short-term and medium-term risks of cancer in patients receiving anti-tumor necrosis factor alpha (anti-TNFalpha) therapies that have proven effective in the treatment of chronic inflammatory conditions. |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 2% |
| United Kingdom | 2 | 1% |
| Netherlands | 1 | <1% |
| Brazil | 1 | <1% |
| Colombia | 1 | <1% |
| Singapore | 1 | <1% |
| Belgium | 1 | <1% |
| Finland | 1 | <1% |
| China | 1 | <1% |
| Other | 3 | 2% |
| Unknown | 124 | 89% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 20% |
| Other | 20 | 14% |
| Student > Ph. D. Student | 16 | 12% |
| Professor > Associate Professor | 10 | 7% |
| Student > Master | 10 | 7% |
| Other | 42 | 30% |
| Unknown | 13 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 92 | 66% |
| Agricultural and Biological Sciences | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Engineering | 3 | 2% |
| Biochemistry, Genetics and Molecular Biology | 2 | 1% |
| Other | 10 | 7% |
| Unknown | 17 | 12% |